CHF 60.00
In stock
SYN-3012-M0011 mgCHF 60.00
SYN-3012-M0055 mgCHF 72.00
SYN-3012-M01010 mgCHF 84.00
SYN-3012-M05050 mgCHF 329.00
SYN-3012-M100100 mgCHF 539.00
More Information
Product Details
Synonyms VFEND-UK-109-496
Product Type Chemical
Formula C16H14F3N5O
MW 349.3
CAS 137234-62-9
Purity Chemicals ≥95%
Appearance Solid.
Solubility Soluble in DMSO or ethanol.
Declaration Manufactured by SynKinase.
Other Product Data Target: N/A | Kinase Group: Pfizer Licensed | Substrate: N/A

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Voriconazole (VFEND) is a triazole antifungal medication that is generally used to treat serious, invasive fungal infections. It is used to treat invasive fungal infections that are generally seen in patients who are immunocompromised. These include invasive candidiasis, invasive aspergillosis, and emerging fungal infections. Voriconzole shows anti-Candida albicans activity at 0.007-8 micrograms/mL is assays. Voriconzole is a potent cytochrome P450 inhibitor with IC50's in the low to mid micromolar range. Voriconazole shows potent antitrypanosomal activity (IC50=95.6nM) against amastigote stage of Trypanosoma cruzi infected in mouse NIH/3T3 cells.
Product References
  1. Antifungal activity of the new azole UK-109 496 (voriconazole): addition and clarification: R. Kappe, et al.; Mycoses 44, 432 (2001)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.